You are here

Botox

Hugel Aesthetics Breaks Into US Market with Letybo: A New Challenger for Botox

BNN

Mon, 03/4/24 - 11:50 pm

AbbVie expects Botox to maintain market share as competition heats up

Reuters

Wed, 01/10/24 - 06:24 pm

Revance Therapeutics

US consumer group seeks stronger warnings on Botox, similar treatments

Reuters

Tue, 12/12/23 - 10:02 am

Revance Therapeutics

Supernus Pharmaceuticals

Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake

Fierce Pharma

Tue, 11/28/23 - 11:29 pm

Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox

Fierce Pharma

Wed, 09/20/23 - 08:57 am

Revance Therapeutics

With trial win, AbbVie cues up Botox for another cosmetic indication

Fierce Pharma

Mon, 09/18/23 - 07:47 pm

platysma prominence

Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle

Fierce Pharma

Mon, 07/3/23 - 10:44 am

Revance Therapeutics

pharma marketing

Bocox for Erectile Dysfunction Announced by the Cellular Medicine Association

Drugs.com

Thu, 12/8/22 - 11:19 pm

erectile dysfunction

Cellular Medicine Association

Goldman Sachs says this biotech working on a Botox rival drug could rally nearly 30%

CNBC

Fri, 09/23/22 - 10:52 am

Revance Therapeutics

AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved

Endpoints

Tue, 09/13/22 - 08:06 pm

Revance Therapeutics

Longer-lasting Botox competitor nabs FDA approval — can it compete with AbbVie's $2B cash cow?

Endpoints

Thu, 09/8/22 - 11:04 am

Revance Therapeutics

Revance Receives FDA Acceptance of BLA Resubmission for DaxibotulinumtoxinA for Injection for Glabellar Lines

BioSpace

Fri, 04/22/22 - 10:15 am

Revance Therapeutics

glabellar lines

daxibotulinumtoxinA

Revance's Botox rival turned away by FDA after inspectors flagged manufacturing 'deficiencies'

Fierce Pharma

Mon, 10/18/21 - 11:10 am

Revance Therapeutics

daxibotulinumtoxinA

AbbVie's Botox patent lawsuit is 'very unlikely to derail' Revance's rival launch: analysts

Fierce Pharma

Mon, 10/11/21 - 09:46 pm

Can Evolus Disrupt the Botox Market?

Motley Fool

Mon, 07/5/21 - 09:47 pm

AbbVie's Botox rolls out the red carpet for real people in new documentary-style ads

Fierce Pharma

Wed, 06/9/21 - 11:08 am

DTC advertising

AbbVie puts an end to Botox trade secrets suit, imposes royalty, license deal on competitor Evolus

Endpoints

Fri, 02/19/21 - 10:43 am

AbbVie adds to the Botox war chest with a 12th FDA approval — but competition is fast approaching

Endpoints

Wed, 02/10/21 - 10:39 pm

bladder muscle overactivity

Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox

Biopharma Reporter

Tue, 12/22/20 - 10:51 am

drug manufacturing

daxiabotulinumtoxinA

AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft

Fierce Pharma

Thu, 12/17/20 - 06:26 pm

Pages